Dr. Rachna T. Shroff discussed the CIRCULATE and COBRA studies at the ASCO Gastrointestinal Cancers Symposium. These studies evaluated the role of circulating tumor DNA in guiding treatment decisions for patients with colon cancer. Dr. Shroff emphasized that these studies show advancements in integrating novel technologies, therapies, and multidisciplinary techniques to bring about the best outcomes for patients. The studies presented at the symposium indicate progress in the field and potentially changing practices. References to the studies are provided.
Source link
Role of circulating tumor DNA in guiding therapeutic choices for colon emphasized
